nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketotifen—PGD—Methotrexate—bone cancer	0.744	1	CbGbCtD
Ketotifen—PDE8B—leg—bone cancer	0.0241	0.187	CbGeAlD
Ketotifen—PDE8B—forelimb—bone cancer	0.0239	0.186	CbGeAlD
Ketotifen—PDE8B—hindlimb—bone cancer	0.0215	0.167	CbGeAlD
Ketotifen—PDE8B—appendage—bone cancer	0.0185	0.144	CbGeAlD
Ketotifen—HRH1—nose—bone cancer	0.0113	0.0878	CbGeAlD
Ketotifen—PDE7B—tendon—bone cancer	0.00455	0.0354	CbGeAlD
Ketotifen—Azatadine—CYP3A4—bone cancer	0.00333	0.513	CrCbGaD
Ketotifen—PDE8A—tendon—bone cancer	0.00326	0.0253	CbGeAlD
Ketotifen—Loratadine—CYP3A4—bone cancer	0.00315	0.487	CrCbGaD
Ketotifen—PDE8A—spinal cord—bone cancer	0.00315	0.0244	CbGeAlD
Ketotifen—PDE4D—tendon—bone cancer	0.00296	0.023	CbGeAlD
Ketotifen—PGD—connective tissue—bone cancer	0.00288	0.0224	CbGeAlD
Ketotifen—PGD—tendon—bone cancer	0.00198	0.0154	CbGeAlD
Ketotifen—PGD—bone marrow—bone cancer	0.00192	0.0149	CbGeAlD
Ketotifen—PGD—spinal cord—bone cancer	0.00191	0.0148	CbGeAlD
Ketotifen—PDE4B—tendon—bone cancer	0.00156	0.0121	CbGeAlD
Ketotifen—PDE4B—bone marrow—bone cancer	0.00151	0.0117	CbGeAlD
Ketotifen—PDE4B—spinal cord—bone cancer	0.0015	0.0117	CbGeAlD
Ketotifen—HRH1—connective tissue—bone cancer	0.0013	0.0101	CbGeAlD
Ketotifen—Haematochezia—Epirubicin—bone cancer	0.001	0.0396	CcSEcCtD
Ketotifen—Infection—Carboplatin—bone cancer	0.000949	0.0375	CcSEcCtD
Ketotifen—Haematochezia—Doxorubicin—bone cancer	0.000926	0.0366	CcSEcCtD
Ketotifen—HRH1—tendon—bone cancer	0.000897	0.00696	CbGeAlD
Ketotifen—Pain—Carboplatin—bone cancer	0.000816	0.0323	CcSEcCtD
Ketotifen—Body temperature increased—Carboplatin—bone cancer	0.000755	0.0298	CcSEcCtD
Ketotifen—Irritability—Cisplatin—bone cancer	0.000544	0.0215	CcSEcCtD
Ketotifen—Stinging—Epirubicin—bone cancer	0.000498	0.0197	CcSEcCtD
Ketotifen—Stinging—Doxorubicin—bone cancer	0.00046	0.0182	CcSEcCtD
Ketotifen—Hepatic enzyme increased—Methotrexate—bone cancer	0.000455	0.018	CcSEcCtD
Ketotifen—PDE8A—Signaling by GPCR—SMO—bone cancer	0.000445	0.00465	CbGpPWpGaD
Ketotifen—PDE8B—Signaling by GPCR—SMO—bone cancer	0.000445	0.00465	CbGpPWpGaD
Ketotifen—HRH1—G alpha (q) signalling events—GRM1—bone cancer	0.000435	0.00455	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—GRM4—bone cancer	0.000433	0.00453	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—RGS1—bone cancer	0.000433	0.00453	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—RGS1—bone cancer	0.00043	0.0045	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—GRM4—bone cancer	0.00043	0.0045	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—RGS1—bone cancer	0.00043	0.0045	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—GRM4—bone cancer	0.00043	0.0045	CbGpPWpGaD
Ketotifen—Cystitis noninfective—Methotrexate—bone cancer	0.000421	0.0166	CcSEcCtD
Ketotifen—Cystitis—Methotrexate—bone cancer	0.000416	0.0164	CcSEcCtD
Ketotifen—PDE8B—Signaling by GPCR—GNA11—bone cancer	0.000407	0.00425	CbGpPWpGaD
Ketotifen—PDE8A—Signaling by GPCR—GNA11—bone cancer	0.000407	0.00425	CbGpPWpGaD
Ketotifen—PDE8B—GPCR downstream signaling—IL3—bone cancer	0.000406	0.00425	CbGpPWpGaD
Ketotifen—PDE8A—GPCR downstream signaling—IL3—bone cancer	0.000406	0.00425	CbGpPWpGaD
Ketotifen—PDE7B—GPCR downstream signaling—GNA11—bone cancer	0.0004	0.00418	CbGpPWpGaD
Ketotifen—PDE7B—Signaling by GPCR—SMO—bone cancer	0.000397	0.00415	CbGpPWpGaD
Ketotifen—Cystitis noninfective—Epirubicin—bone cancer	0.000394	0.0156	CcSEcCtD
Ketotifen—PDE4C—Signaling by GPCR—GRM4—bone cancer	0.000393	0.00411	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—RGS1—bone cancer	0.000393	0.00411	CbGpPWpGaD
Ketotifen—Bladder pain—Methotrexate—bone cancer	0.000389	0.0154	CcSEcCtD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.000389	0.00407	CbGpPWpGaD
Ketotifen—Cystitis—Epirubicin—bone cancer	0.000389	0.0154	CcSEcCtD
Ketotifen—PDE7B—Signaling Pathways—RGS1—bone cancer	0.000384	0.00401	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—GRM4—bone cancer	0.000384	0.00401	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—RGS1—bone cancer	0.000377	0.00394	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—GRM4—bone cancer	0.000377	0.00394	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—GRM1—bone cancer	0.000376	0.00393	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—GRM1—bone cancer	0.000373	0.0039	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—GRM1—bone cancer	0.000373	0.0039	CbGpPWpGaD
Ketotifen—Dry eye—Epirubicin—bone cancer	0.000372	0.0147	CcSEcCtD
Ketotifen—PDE7A—GPCR downstream signaling—GNA11—bone cancer	0.000371	0.00388	CbGpPWpGaD
Ketotifen—PDE8A—Signaling by GPCR—IL3—bone cancer	0.000369	0.00386	CbGpPWpGaD
Ketotifen—PDE8B—Signaling by GPCR—IL3—bone cancer	0.000369	0.00386	CbGpPWpGaD
Ketotifen—PDE7A—Signaling by GPCR—SMO—bone cancer	0.000369	0.00385	CbGpPWpGaD
Ketotifen—Bladder pain—Epirubicin—bone cancer	0.000364	0.0144	CcSEcCtD
Ketotifen—Cystitis noninfective—Doxorubicin—bone cancer	0.000364	0.0144	CcSEcCtD
Ketotifen—PDE7B—Signaling by GPCR—GNA11—bone cancer	0.000363	0.00379	CbGpPWpGaD
Ketotifen—PDE7B—GPCR downstream signaling—IL3—bone cancer	0.000362	0.00379	CbGpPWpGaD
Ketotifen—Cystitis—Doxorubicin—bone cancer	0.00036	0.0142	CcSEcCtD
Ketotifen—PDE4A—GPCR downstream signaling—RGS1—bone cancer	0.000359	0.00375	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—GRM4—bone cancer	0.000359	0.00375	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—GRM4—bone cancer	0.000357	0.00373	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—RGS1—bone cancer	0.000357	0.00373	CbGpPWpGaD
Ketotifen—Dry eye—Doxorubicin—bone cancer	0.000345	0.0136	CcSEcCtD
Ketotifen—PDE4D—Signaling by GPCR—GRM4—bone cancer	0.000342	0.00358	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—RGS1—bone cancer	0.000342	0.00358	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—GRM1—bone cancer	0.000341	0.00357	CbGpPWpGaD
Ketotifen—PDE7A—Signaling by GPCR—GNA11—bone cancer	0.000337	0.00353	CbGpPWpGaD
Ketotifen—Bladder pain—Doxorubicin—bone cancer	0.000337	0.0133	CcSEcCtD
Ketotifen—PDE7A—GPCR downstream signaling—IL3—bone cancer	0.000337	0.00352	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—GRM1—bone cancer	0.000333	0.00348	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—GRM4—bone cancer	0.000332	0.00347	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—RGS1—bone cancer	0.000332	0.00347	CbGpPWpGaD
Ketotifen—PDE7B—Signaling by GPCR—IL3—bone cancer	0.000329	0.00344	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—GRM1—bone cancer	0.000327	0.00342	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—GRM4—bone cancer	0.000326	0.00341	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—RGS1—bone cancer	0.000326	0.00341	CbGpPWpGaD
Ketotifen—Increased appetite—Epirubicin—bone cancer	0.000311	0.0123	CcSEcCtD
Ketotifen—PDE4A—GPCR downstream signaling—GRM1—bone cancer	0.000311	0.00325	CbGpPWpGaD
Ketotifen—PDE4D—Myometrial Relaxation and Contraction Pathways—JUN—bone cancer	0.000311	0.00325	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—GRM1—bone cancer	0.000309	0.00323	CbGpPWpGaD
Ketotifen—PDE7A—Signaling by GPCR—IL3—bone cancer	0.000306	0.0032	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—RGS1—bone cancer	0.000302	0.00315	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—GRM4—bone cancer	0.000302	0.00315	CbGpPWpGaD
Ketotifen—Irritability—Methotrexate—bone cancer	0.000298	0.0118	CcSEcCtD
Ketotifen—PDE4D—Signaling by GPCR—GRM1—bone cancer	0.000297	0.0031	CbGpPWpGaD
Ketotifen—Increased appetite—Doxorubicin—bone cancer	0.000288	0.0114	CcSEcCtD
Ketotifen—PDE4B—GPCR downstream signaling—GRM1—bone cancer	0.000288	0.00301	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—GRM1—bone cancer	0.000283	0.00295	CbGpPWpGaD
Ketotifen—PGD—Disease—ENO2—bone cancer	0.000282	0.00295	CbGpPWpGaD
Ketotifen—HRH1—G alpha (q) signalling events—GNA11—bone cancer	0.000281	0.00293	CbGpPWpGaD
Ketotifen—Infection—Cisplatin—bone cancer	0.000278	0.011	CcSEcCtD
Ketotifen—Thrombocytopenia—Cisplatin—bone cancer	0.000274	0.0108	CcSEcCtD
Ketotifen—PDE4B—Myometrial Relaxation and Contraction Pathways—JUN—bone cancer	0.000274	0.00286	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—SMO—bone cancer	0.000263	0.00275	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—SMO—bone cancer	0.000263	0.00275	CbGpPWpGaD
Ketotifen—PGD—Disease—DHFR—bone cancer	0.000262	0.00274	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—GRM1—bone cancer	0.000262	0.00273	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—GRM4—bone cancer	0.000253	0.00265	CbGpPWpGaD
Ketotifen—Paraesthesia—Cisplatin—bone cancer	0.000251	0.00994	CcSEcCtD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000251	0.00262	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—GNA11—bone cancer	0.000242	0.00253	CbGpPWpGaD
Ketotifen—Drowsiness—Methotrexate—bone cancer	0.000241	0.00952	CcSEcCtD
Ketotifen—PDE8B—Signaling Pathways—GNA11—bone cancer	0.00024	0.00251	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—GNA11—bone cancer	0.00024	0.00251	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—SMO—bone cancer	0.00024	0.00251	CbGpPWpGaD
Ketotifen—Pain—Cisplatin—bone cancer	0.000239	0.00947	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000239	0.00944	CcSEcCtD
Ketotifen—PGD—Metabolism—ENO2—bone cancer	0.000236	0.00247	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—SMO—bone cancer	0.000234	0.00245	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—GRM4—bone cancer	0.000232	0.00243	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—RGS1—bone cancer	0.000232	0.00243	CbGpPWpGaD
Ketotifen—Weight increased—Epirubicin—bone cancer	0.00023	0.0091	CcSEcCtD
Ketotifen—Epistaxis—Methotrexate—bone cancer	0.000227	0.00898	CcSEcCtD
Ketotifen—Drowsiness—Epirubicin—bone cancer	0.000226	0.00891	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000224	0.00884	CcSEcCtD
Ketotifen—PDE8A—Signaling Pathways—ATF1—bone cancer	0.000224	0.00234	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—ATF1—bone cancer	0.000224	0.00234	CbGpPWpGaD
Ketotifen—Body temperature increased—Cisplatin—bone cancer	0.000221	0.00875	CcSEcCtD
Ketotifen—PDE4C—Signaling by GPCR—GNA11—bone cancer	0.00022	0.0023	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—GRM1—bone cancer	0.00022	0.0023	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—IL3—bone cancer	0.000219	0.00229	CbGpPWpGaD
Ketotifen—PGD—Metabolism—DHFR—bone cancer	0.000219	0.00229	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—IL3—bone cancer	0.000218	0.00228	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—IL3—bone cancer	0.000218	0.00228	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—SMO—bone cancer	0.000218	0.00228	CbGpPWpGaD
Ketotifen—Hepatitis—Methotrexate—bone cancer	0.000216	0.00855	CcSEcCtD
Ketotifen—PDE7B—Signaling Pathways—GNA11—bone cancer	0.000214	0.00224	CbGpPWpGaD
Ketotifen—Weight increased—Doxorubicin—bone cancer	0.000213	0.00842	CcSEcCtD
Ketotifen—Epistaxis—Epirubicin—bone cancer	0.000213	0.00841	CcSEcCtD
Ketotifen—PDE4D—GPCR downstream signaling—GNA11—bone cancer	0.000211	0.0022	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—SMO—bone cancer	0.000209	0.00219	CbGpPWpGaD
Ketotifen—Drowsiness—Doxorubicin—bone cancer	0.000209	0.00825	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000207	0.00818	CcSEcCtD
Ketotifen—PGD—Metabolism—GNA11—bone cancer	0.000205	0.00214	CbGpPWpGaD
Ketotifen—Erythema multiforme—Methotrexate—bone cancer	0.000205	0.00808	CcSEcCtD
Ketotifen—Hepatitis—Epirubicin—bone cancer	0.000202	0.008	CcSEcCtD
Ketotifen—PDE4D—Signaling Pathways—RGS1—bone cancer	0.000202	0.00211	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—GRM4—bone cancer	0.000202	0.00211	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—GRM1—bone cancer	0.000202	0.00211	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—GNA11—bone cancer	0.000201	0.0021	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—IL3—bone cancer	0.000199	0.00208	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—GNA11—bone cancer	0.000199	0.00208	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—ATF1—bone cancer	0.000199	0.00208	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—SMO—bone cancer	0.000199	0.00208	CbGpPWpGaD
Ketotifen—Epistaxis—Doxorubicin—bone cancer	0.000197	0.00778	CcSEcCtD
Ketotifen—PDE7B—Signaling Pathways—IL3—bone cancer	0.000194	0.00203	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—GRM4—bone cancer	0.000193	0.00201	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—RGS1—bone cancer	0.000193	0.00201	CbGpPWpGaD
Ketotifen—Diarrhoea—Cisplatin—bone cancer	0.000192	0.00757	CcSEcCtD
Ketotifen—Erythema multiforme—Epirubicin—bone cancer	0.000191	0.00757	CcSEcCtD
Ketotifen—PDE4D—Signaling by GPCR—GNA11—bone cancer	0.000191	0.002	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—IL3—bone cancer	0.000191	0.002	CbGpPWpGaD
Ketotifen—PGD—Disease—TGFBR2—bone cancer	0.00019	0.00198	CbGpPWpGaD
Ketotifen—Hepatitis—Doxorubicin—bone cancer	0.000187	0.0074	CcSEcCtD
Ketotifen—PDE8B—Signaling Pathways—TGFBR2—bone cancer	0.000186	0.00195	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—TGFBR2—bone cancer	0.000186	0.00195	CbGpPWpGaD
Ketotifen—PGD—Metabolism—CYP3A4—bone cancer	0.000186	0.00194	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—GNA11—bone cancer	0.000186	0.00194	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—ATF1—bone cancer	0.000185	0.00194	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—SMO—bone cancer	0.000184	0.00193	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—GNA11—bone cancer	0.000182	0.0019	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—IL3—bone cancer	0.000182	0.0019	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—IL3—bone cancer	0.000181	0.00189	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—GRM4—bone cancer	0.000178	0.00186	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—RGS1—bone cancer	0.000178	0.00186	CbGpPWpGaD
Ketotifen—Vomiting—Cisplatin—bone cancer	0.000178	0.00704	CcSEcCtD
Ketotifen—Erythema multiforme—Doxorubicin—bone cancer	0.000177	0.007	CcSEcCtD
Ketotifen—Rash—Cisplatin—bone cancer	0.000177	0.00698	CcSEcCtD
Ketotifen—Dermatitis—Cisplatin—bone cancer	0.000176	0.00697	CcSEcCtD
Ketotifen—PDE8B—Signaling Pathways—IGF1R—bone cancer	0.000175	0.00183	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—IGF1R—bone cancer	0.000175	0.00183	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—GRM1—bone cancer	0.000175	0.00183	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—IL3—bone cancer	0.000173	0.00181	CbGpPWpGaD
Ketotifen—Tension—Epirubicin—bone cancer	0.000173	0.00684	CcSEcCtD
Ketotifen—Nervousness—Epirubicin—bone cancer	0.000171	0.00677	CcSEcCtD
Ketotifen—PDE4B—Signaling by GPCR—GNA11—bone cancer	0.000169	0.00176	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—IL3—bone cancer	0.000168	0.00176	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—GRM1—bone cancer	0.000167	0.00175	CbGpPWpGaD
Ketotifen—Nausea—Cisplatin—bone cancer	0.000166	0.00658	CcSEcCtD
Ketotifen—PDE7B—Signaling Pathways—TGFBR2—bone cancer	0.000166	0.00174	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—IL3—bone cancer	0.000165	0.00173	CbGpPWpGaD
Ketotifen—Tension—Doxorubicin—bone cancer	0.00016	0.00632	CcSEcCtD
Ketotifen—PGD—Metabolism—GSTP1—bone cancer	0.000159	0.00166	CbGpPWpGaD
Ketotifen—Nervousness—Doxorubicin—bone cancer	0.000158	0.00626	CcSEcCtD
Ketotifen—Syncope—Epirubicin—bone cancer	0.000158	0.00625	CcSEcCtD
Ketotifen—PDE7B—Signaling Pathways—IGF1R—bone cancer	0.000156	0.00163	CbGpPWpGaD
Ketotifen—Loss of consciousness—Epirubicin—bone cancer	0.000155	0.00612	CcSEcCtD
Ketotifen—HRH1—GPCR ligand binding—SMO—bone cancer	0.000155	0.00162	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—TGFBR2—bone cancer	0.000154	0.00161	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—GRM1—bone cancer	0.000154	0.00161	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—IL3—bone cancer	0.000153	0.0016	CbGpPWpGaD
Ketotifen—Infection—Methotrexate—bone cancer	0.000153	0.00604	CcSEcCtD
Ketotifen—Hypertension—Epirubicin—bone cancer	0.000152	0.00601	CcSEcCtD
Ketotifen—Thrombocytopenia—Methotrexate—bone cancer	0.00015	0.00595	CcSEcCtD
Ketotifen—Dry mouth—Epirubicin—bone cancer	0.000147	0.0058	CcSEcCtD
Ketotifen—Syncope—Doxorubicin—bone cancer	0.000146	0.00578	CcSEcCtD
Ketotifen—PDE7A—Signaling Pathways—IGF1R—bone cancer	0.000145	0.00152	CbGpPWpGaD
Ketotifen—Loss of consciousness—Doxorubicin—bone cancer	0.000143	0.00566	CcSEcCtD
Ketotifen—HRH1—GPCR downstream signaling—RGS1—bone cancer	0.000143	0.0015	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—GRM4—bone cancer	0.000143	0.0015	CbGpPWpGaD
Ketotifen—Infection—Epirubicin—bone cancer	0.000143	0.00565	CcSEcCtD
Ketotifen—PDE4C—Signaling Pathways—SMO—bone cancer	0.000142	0.00148	CbGpPWpGaD
Ketotifen—Shock—Epirubicin—bone cancer	0.000141	0.00559	CcSEcCtD
Ketotifen—Thrombocytopenia—Epirubicin—bone cancer	0.000141	0.00557	CcSEcCtD
Ketotifen—Hypertension—Doxorubicin—bone cancer	0.000141	0.00556	CcSEcCtD
Ketotifen—Insomnia—Methotrexate—bone cancer	0.000139	0.00549	CcSEcCtD
Ketotifen—Paraesthesia—Methotrexate—bone cancer	0.000138	0.00545	CcSEcCtD
Ketotifen—Somnolence—Methotrexate—bone cancer	0.000137	0.0054	CcSEcCtD
Ketotifen—Dry mouth—Doxorubicin—bone cancer	0.000136	0.00537	CcSEcCtD
Ketotifen—Infection—Doxorubicin—bone cancer	0.000132	0.00523	CcSEcCtD
Ketotifen—Pain—Methotrexate—bone cancer	0.000131	0.00519	CcSEcCtD
Ketotifen—Shock—Doxorubicin—bone cancer	0.000131	0.00518	CcSEcCtD
Ketotifen—Thrombocytopenia—Doxorubicin—bone cancer	0.00013	0.00515	CcSEcCtD
Ketotifen—Insomnia—Epirubicin—bone cancer	0.00013	0.00514	CcSEcCtD
Ketotifen—HRH1—Signaling by GPCR—GRM4—bone cancer	0.00013	0.00136	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—RGS1—bone cancer	0.00013	0.00136	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—GNA11—bone cancer	0.00013	0.00136	CbGpPWpGaD
Ketotifen—PGD—Disease—KIT—bone cancer	0.000129	0.00135	CbGpPWpGaD
Ketotifen—Paraesthesia—Epirubicin—bone cancer	0.000129	0.0051	CcSEcCtD
Ketotifen—Somnolence—Epirubicin—bone cancer	0.000128	0.00505	CcSEcCtD
Ketotifen—PDE8A—Signaling Pathways—KIT—bone cancer	0.000127	0.00133	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—KIT—bone cancer	0.000127	0.00133	CbGpPWpGaD
Ketotifen—Gastrointestinal pain—Methotrexate—bone cancer	0.000126	0.00497	CcSEcCtD
Ketotifen—HRH1—GPCR downstream signaling—GRM1—bone cancer	0.000124	0.0013	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—SMO—bone cancer	0.000124	0.00129	CbGpPWpGaD
Ketotifen—Pain—Epirubicin—bone cancer	0.000123	0.00486	CcSEcCtD
Ketotifen—Urticaria—Methotrexate—bone cancer	0.000122	0.00483	CcSEcCtD
Ketotifen—PGD—Disease—BRAF—bone cancer	0.000122	0.00127	CbGpPWpGaD
Ketotifen—Abdominal pain—Methotrexate—bone cancer	0.000121	0.0048	CcSEcCtD
Ketotifen—Body temperature increased—Methotrexate—bone cancer	0.000121	0.0048	CcSEcCtD
Ketotifen—PDE4C—Signaling Pathways—ATF1—bone cancer	0.000121	0.00126	CbGpPWpGaD
Ketotifen—Insomnia—Doxorubicin—bone cancer	0.00012	0.00476	CcSEcCtD
Ketotifen—PDE8A—Signaling Pathways—BRAF—bone cancer	0.00012	0.00125	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—BRAF—bone cancer	0.00012	0.00125	CbGpPWpGaD
Ketotifen—Paraesthesia—Doxorubicin—bone cancer	0.000119	0.00472	CcSEcCtD
Ketotifen—Somnolence—Doxorubicin—bone cancer	0.000118	0.00468	CcSEcCtD
Ketotifen—PDE4C—Signaling Pathways—IL3—bone cancer	0.000118	0.00123	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—SMO—bone cancer	0.000118	0.00123	CbGpPWpGaD
Ketotifen—Gastrointestinal pain—Epirubicin—bone cancer	0.000118	0.00465	CcSEcCtD
Ketotifen—PDE8A—Signaling by GPCR—EGFR—bone cancer	0.000116	0.00121	CbGpPWpGaD
Ketotifen—PDE8B—Signaling by GPCR—EGFR—bone cancer	0.000116	0.00121	CbGpPWpGaD
Ketotifen—Urticaria—Epirubicin—bone cancer	0.000114	0.00452	CcSEcCtD
Ketotifen—Pain—Doxorubicin—bone cancer	0.000114	0.0045	CcSEcCtD
Ketotifen—Body temperature increased—Epirubicin—bone cancer	0.000114	0.00449	CcSEcCtD
Ketotifen—Abdominal pain—Epirubicin—bone cancer	0.000114	0.00449	CcSEcCtD
Ketotifen—PDE7B—Signaling Pathways—KIT—bone cancer	0.000113	0.00119	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—GNA11—bone cancer	0.000113	0.00118	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—GRM1—bone cancer	0.000113	0.00118	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—SMO—bone cancer	0.000109	0.00114	CbGpPWpGaD
Ketotifen—Gastrointestinal pain—Doxorubicin—bone cancer	0.000109	0.0043	CcSEcCtD
Ketotifen—Pruritus—Methotrexate—bone cancer	0.000109	0.0043	CcSEcCtD
Ketotifen—PDE4A—Signaling Pathways—GNA11—bone cancer	0.000108	0.00112	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—BRAF—bone cancer	0.000107	0.00111	CbGpPWpGaD
Ketotifen—Urticaria—Doxorubicin—bone cancer	0.000106	0.00418	CcSEcCtD
Ketotifen—PDE7A—Signaling Pathways—KIT—bone cancer	0.000105	0.0011	CbGpPWpGaD
Ketotifen—Body temperature increased—Doxorubicin—bone cancer	0.000105	0.00416	CcSEcCtD
Ketotifen—Abdominal pain—Doxorubicin—bone cancer	0.000105	0.00416	CcSEcCtD
Ketotifen—Diarrhoea—Methotrexate—bone cancer	0.000105	0.00416	CcSEcCtD
Ketotifen—PDE4D—Signaling Pathways—ATF1—bone cancer	0.000105	0.0011	CbGpPWpGaD
Ketotifen—PDE7B—Signaling by GPCR—EGFR—bone cancer	0.000103	0.00108	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—IL3—bone cancer	0.000102	0.00107	CbGpPWpGaD
Ketotifen—PGD—Disease—MDM2—bone cancer	0.000102	0.00107	CbGpPWpGaD
Ketotifen—Pruritus—Epirubicin—bone cancer	0.000102	0.00402	CcSEcCtD
Ketotifen—Dizziness—Methotrexate—bone cancer	0.000102	0.00402	CcSEcCtD
Ketotifen—PDE4C—Signaling Pathways—TGFBR2—bone cancer	0.000101	0.00105	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—MDM2—bone cancer	0.0001	0.00105	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—MDM2—bone cancer	0.0001	0.00105	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—ATF1—bone cancer	0.0001	0.00105	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—GNA11—bone cancer	9.96e-05	0.00104	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—BRAF—bone cancer	9.91e-05	0.00104	CbGpPWpGaD
Ketotifen—Diarrhoea—Epirubicin—bone cancer	9.84e-05	0.00389	CcSEcCtD
Ketotifen—PGD—Disease—PTGS2—bone cancer	9.83e-05	0.00103	CbGpPWpGaD
Ketotifen—Vomiting—Methotrexate—bone cancer	9.77e-05	0.00386	CcSEcCtD
Ketotifen—PDE4A—Signaling Pathways—IL3—bone cancer	9.75e-05	0.00102	CbGpPWpGaD
Ketotifen—Rash—Methotrexate—bone cancer	9.69e-05	0.00383	CcSEcCtD
Ketotifen—Dermatitis—Methotrexate—bone cancer	9.68e-05	0.00383	CcSEcCtD
Ketotifen—Headache—Methotrexate—bone cancer	9.63e-05	0.00381	CcSEcCtD
Ketotifen—PDE7A—Signaling by GPCR—EGFR—bone cancer	9.6e-05	0.001	CbGpPWpGaD
Ketotifen—Dizziness—Epirubicin—bone cancer	9.51e-05	0.00376	CcSEcCtD
Ketotifen—PDE4C—Signaling Pathways—IGF1R—bone cancer	9.47e-05	0.00099	CbGpPWpGaD
Ketotifen—Pruritus—Doxorubicin—bone cancer	9.41e-05	0.00372	CcSEcCtD
Ketotifen—PDE4B—Signaling Pathways—ATF1—bone cancer	9.26e-05	0.000967	CbGpPWpGaD
Ketotifen—Vomiting—Epirubicin—bone cancer	9.14e-05	0.00361	CcSEcCtD
Ketotifen—Nausea—Methotrexate—bone cancer	9.13e-05	0.00361	CcSEcCtD
Ketotifen—Diarrhoea—Doxorubicin—bone cancer	9.11e-05	0.0036	CcSEcCtD
Ketotifen—Rash—Epirubicin—bone cancer	9.07e-05	0.00358	CcSEcCtD
Ketotifen—Dermatitis—Epirubicin—bone cancer	9.06e-05	0.00358	CcSEcCtD
Ketotifen—PDE4B—Signaling Pathways—IL3—bone cancer	9.03e-05	0.000943	CbGpPWpGaD
Ketotifen—Headache—Epirubicin—bone cancer	9.01e-05	0.00356	CcSEcCtD
Ketotifen—PDE7B—Signaling Pathways—MDM2—bone cancer	8.93e-05	0.000934	CbGpPWpGaD
Ketotifen—Dizziness—Doxorubicin—bone cancer	8.8e-05	0.00348	CcSEcCtD
Ketotifen—PDE4D—Signaling Pathways—TGFBR2—bone cancer	8.76e-05	0.000916	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—JUN—bone cancer	8.71e-05	0.00091	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—JUN—bone cancer	8.71e-05	0.00091	CbGpPWpGaD
Ketotifen—Nausea—Epirubicin—bone cancer	8.54e-05	0.00338	CcSEcCtD
Ketotifen—PDE8A—Signaling Pathways—MMP9—bone cancer	8.47e-05	0.000886	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—MMP9—bone cancer	8.47e-05	0.000886	CbGpPWpGaD
Ketotifen—Vomiting—Doxorubicin—bone cancer	8.46e-05	0.00334	CcSEcCtD
Ketotifen—Rash—Doxorubicin—bone cancer	8.39e-05	0.00332	CcSEcCtD
Ketotifen—Dermatitis—Doxorubicin—bone cancer	8.38e-05	0.00331	CcSEcCtD
Ketotifen—PDE4A—Signaling Pathways—TGFBR2—bone cancer	8.34e-05	0.000872	CbGpPWpGaD
Ketotifen—Headache—Doxorubicin—bone cancer	8.34e-05	0.0033	CcSEcCtD
Ketotifen—PDE7A—Signaling Pathways—MDM2—bone cancer	8.3e-05	0.000868	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—IGF1R—bone cancer	8.25e-05	0.000862	CbGpPWpGaD
Ketotifen—PGD—Metabolism—PTGS2—bone cancer	8.23e-05	0.00086	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—GNA11—bone cancer	8e-05	0.000836	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—SMO—bone cancer	7.94e-05	0.00083	CbGpPWpGaD
Ketotifen—Nausea—Doxorubicin—bone cancer	7.9e-05	0.00312	CcSEcCtD
Ketotifen—PDE4A—Signaling Pathways—IGF1R—bone cancer	7.85e-05	0.00082	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—JUN—bone cancer	7.76e-05	0.000811	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—TGFBR2—bone cancer	7.72e-05	0.000807	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—GRM4—bone cancer	7.68e-05	0.000803	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—RGS1—bone cancer	7.68e-05	0.000803	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—MMP9—bone cancer	7.55e-05	0.000789	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—IGF1R—bone cancer	7.26e-05	0.000759	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—GNA11—bone cancer	7.26e-05	0.000759	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—IL3—bone cancer	7.25e-05	0.000758	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—JUN—bone cancer	7.22e-05	0.000754	CbGpPWpGaD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	7.15e-05	0.000747	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—MMP9—bone cancer	7.02e-05	0.000734	CbGpPWpGaD
Ketotifen—PGD—Disease—EGFR—bone cancer	6.97e-05	0.000728	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—KIT—bone cancer	6.87e-05	0.000718	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—EGFR—bone cancer	6.85e-05	0.000716	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—EGFR—bone cancer	6.85e-05	0.000716	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—GRM1—bone cancer	6.66e-05	0.000696	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—IL3—bone cancer	6.58e-05	0.000688	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—BRAF—bone cancer	6.46e-05	0.000675	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—EGFR—bone cancer	6.26e-05	0.000654	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—EGFR—bone cancer	6.1e-05	0.000638	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—KIT—bone cancer	5.98e-05	0.000625	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—TP53—bone cancer	5.75e-05	0.000601	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—TP53—bone cancer	5.75e-05	0.000601	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—KIT—bone cancer	5.69e-05	0.000595	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—EGFR—bone cancer	5.67e-05	0.000593	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—BRAF—bone cancer	5.62e-05	0.000588	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—EGFR—bone cancer	5.45e-05	0.00057	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MDM2—bone cancer	5.41e-05	0.000566	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—BRAF—bone cancer	5.35e-05	0.000559	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—KIT—bone cancer	5.27e-05	0.000551	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—EGFR—bone cancer	5.19e-05	0.000542	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—TP53—bone cancer	5.12e-05	0.000536	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—BRAF—bone cancer	4.95e-05	0.000518	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—EGFR—bone cancer	4.8e-05	0.000502	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—TP53—bone cancer	4.76e-05	0.000498	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MDM2—bone cancer	4.71e-05	0.000492	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—JUN—bone cancer	4.7e-05	0.000492	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SMO—bone cancer	4.69e-05	0.00049	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MMP9—bone cancer	4.58e-05	0.000478	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MDM2—bone cancer	4.48e-05	0.000469	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—GNA11—bone cancer	4.29e-05	0.000448	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MDM2—bone cancer	4.15e-05	0.000434	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—JUN—bone cancer	4.09e-05	0.000428	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ATF1—bone cancer	3.99e-05	0.000417	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MMP9—bone cancer	3.98e-05	0.000416	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—JUN—bone cancer	3.9e-05	0.000407	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IL3—bone cancer	3.89e-05	0.000407	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MMP9—bone cancer	3.79e-05	0.000396	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—EGFR—bone cancer	3.7e-05	0.000387	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—JUN—bone cancer	3.61e-05	0.000377	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MMP9—bone cancer	3.51e-05	0.000367	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TGFBR2—bone cancer	3.33e-05	0.000348	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—EGFR—bone cancer	3.22e-05	0.000336	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IGF1R—bone cancer	3.13e-05	0.000327	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—TP53—bone cancer	3.1e-05	0.000325	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—EGFR—bone cancer	3.06e-05	0.00032	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—EGFR—bone cancer	2.83e-05	0.000296	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—TP53—bone cancer	2.7e-05	0.000283	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—TP53—bone cancer	2.57e-05	0.000269	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—TP53—bone cancer	2.38e-05	0.000249	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—KIT—bone cancer	2.27e-05	0.000237	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—BRAF—bone cancer	2.13e-05	0.000223	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—EGFR—bone cancer	2.07e-05	0.000216	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MDM2—bone cancer	1.79e-05	0.000187	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—JUN—bone cancer	1.55e-05	0.000162	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MMP9—bone cancer	1.51e-05	0.000158	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—EGFR—bone cancer	1.22e-05	0.000128	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TP53—bone cancer	1.03e-05	0.000107	CbGpPWpGaD
